These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34666651)

  • 21. Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children.
    Varon E; Cohen R; Béchet S; Doit C; Levy C
    Vaccine; 2015 Nov; 33(46):6178-85. PubMed ID: 26476365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
    Cho EY; Choi EH; Kang JH; Kim KH; Kim DS; Kim YJ; Ahn YM; Eun BW; Oh SH; Cha SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Kim JH; Lee H; Lee T; Kim HM; Lee KS; Kim CS; Park SE; Kim YM; Oh CE; Ma SH; Jo DS; Choi YY; Lee J; Bae GR; Park O; Park YJ; Kim ES; Lee HJ
    J Korean Med Sci; 2016 Jul; 31(7):1082-8. PubMed ID: 27366006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.
    Demczuk WHB; Martin I; Desai S; Griffith A; Caron-Poulin L; Lefebvre B; McGeer A; Tyrrell GJ; Zhanel GG; Gubbay J; Hoang L; Levett PN; Van Caeseele P; Raafat Gad R; Haldane D; Zahariadis G; German G; Daley Bernier J; Strudwick L; Mulvey MR
    Vaccine; 2018 Jul; 36(31):4701-4707. PubMed ID: 29937245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.
    Demczuk WH; Martin I; Griffith A; Lefebvre B; McGeer A; Lovgren M; Tyrrell GJ; Desai S; Sherrard L; Adam H; Gilmour M; Zhanel GG; ;
    Can J Microbiol; 2013 Dec; 59(12):778-88. PubMed ID: 24313450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotype distribution, antibiotic resistance pattern, and multilocus sequence types of invasive Streptococcus pneumoniae isolates in two tertiary pediatric hospitals in Beijing prior to PCV13 availability.
    Shi W; Li J; Dong F; Qian S; Liu G; Xu B; Zhou L; Xu W; Meng Q; Wang Q; Shen K; Ma L; Yao K
    Expert Rev Vaccines; 2019 Jan; 18(1):89-94. PubMed ID: 30526145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018.
    Hu T; Song Y; Done N; Liu Q; Sarpong EM; Lemus-Wirtz E; Signorovitch J; Mohanty S; Weiss T
    BMC Public Health; 2022 Sep; 22(1):1677. PubMed ID: 36064378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
    Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; Del Castillo F; Hernández-Sampelayo T; Otheo E; Balboa F; Ríos E; Méndez C;
    Clin Vaccine Immunol; 2011 Jan; 18(1):89-94. PubMed ID: 21047996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden.
    Bergman K; Härnqvist T; Backhaus E; Trollfors B; Dahl MS; Kolberg H; Ockborn G; Andersson R; Karlsson J; Mellgren Å; Skovbjerg S
    BMC Infect Dis; 2021 Aug; 21(1):756. PubMed ID: 34348674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study.
    Fenoll A; Ardanuy C; Liñares J; Cercenado E; Marco F; Fleites A; Rodríguez-Mayo M; López-Hontangas JL; Palop B; Aller AI; Buendía B; Méndez C; Cifuentes I;
    Vaccine; 2018 Dec; 36(52):7993-8000. PubMed ID: 30449634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serotype distribution and antibiotic resistance of Streptococcus pneumoniae strains isolated from the adult patients in a Turkish üniversity hospital].
    Öksüz L; Gürler N
    Mikrobiyol Bul; 2017 Jul; 51(3):195-208. PubMed ID: 28929957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
    van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
    Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.
    Ben-Shimol S; Greenberg D; Givon-Lavi N; Elias N; Glikman D; Rubinstein U; Dagan R;
    Vaccine; 2012 Oct; 30(46):6600-7. PubMed ID: 22939907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use.
    Baxter R; Aukes L; Pelton SI; Yee A; Klein NP; Gruber WC; Scott DA; Center KJ
    J Pediatric Infect Dis Soc; 2021 Mar; 10(2):141-150. PubMed ID: 32415771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.
    Lo SW; Gladstone RA; van Tonder AJ; Lees JA; du Plessis M; Benisty R; Givon-Lavi N; Hawkins PA; Cornick JE; Kwambana-Adams B; Law PY; Ho PL; Antonio M; Everett DB; Dagan R; von Gottberg A; Klugman KP; McGee L; Breiman RF; Bentley SD;
    Lancet Infect Dis; 2019 Jul; 19(7):759-769. PubMed ID: 31196809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.
    Yildirim I; Stevenson A; Hsu KK; Pelton SI
    Pediatr Infect Dis J; 2012 Oct; 31(10):1016-21. PubMed ID: 22673142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.
    Olarte L; Ampofo K; Stockmann C; Mason EO; Daly JA; Pavia AT; Byington CL
    Pediatrics; 2013 Jul; 132(1):e17-24. PubMed ID: 23733800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.